Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McDonnell

Showing results (371-380 of 374) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 374 results.
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Journal of Medicinal Chemistry|July 10, 2026
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365Deborah S Mortensen, Surendra Nayak, Veronique Plantevin-Krenitsky, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Rare variants in <i>PPFIA3</i> cause delayed development, intellectual disability, autism, and epilepsyMaimuna S Paul, Sydney L Michener, Hongling Pan, et al.
American Journal of Human Genetics|January 5, 2024
A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3Maimuna S Paul, Sydney L Michener, Hongling Pan, et al.
Pageof 38

Showing results (371-380 of 374) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 374 results.
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Journal of Medicinal Chemistry|July 10, 2026
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365Deborah S Mortensen, Surendra Nayak, Veronique Plantevin-Krenitsky, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Rare variants in <i>PPFIA3</i> cause delayed development, intellectual disability, autism, and epilepsyMaimuna S Paul, Sydney L Michener, Hongling Pan, et al.
American Journal of Human Genetics|January 5, 2024
A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3Maimuna S Paul, Sydney L Michener, Hongling Pan, et al.
Pageof 38